Tetragenetics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Tetragenetics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10572
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tetragenetics Inc (Tetragenetics) is a biotechnology company that discovers and develops therapeutics for autoimmune disease and pain. The company develops antibodies for autoimmune disorders, pains and other. Its autoimmune disorders include Type 1 Diabetes Mellitus, rheumatoid arthritis, multiple sclerosis, psoriasis, lupus and others. The company’s drug developing technologies comprise ion channels, tetraexpress, and antibody discovery. Tetragenetics has partnered with various companies for drug discovery. The company provides drug discovery and development programs channels included in pathogenesis of autoimmunity and pain. Tetragenetics is headquartered in Arlington, Massachusetts, the US.

Tetragenetics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tetragenetics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tetragenetics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
TetraGenetics Raises Funds through Venture Financing 11
Tetragenetics Raises USD1 Million in Venture Financing 12
Tetragenetics Raises USD0.3 Million in Financing Round 13
Tetragenetics Raises US$0.5 Million In Venture Financing 14
Tetragenetics Raises US$3 Million In Venture Financing 15
Partnerships 16
Tetragenetics Enters into Agreement with LifeArc 16
Tetragenetics Enters into Partnership with Modiquest Research 17
Tetragenetics Enters into Agreement with Theranyx 18
Tetragenetics Enters into Agreement with arGEN-X, Crystal Biosciences and Sevion Therapeutics 19
Tetragenetics Enters into Agreement with MedImmune for Drug Discovery Program 20
Licensing Agreements 21
Tetragenetics Enters Into Option For Licensing Agreement With Pfizer For SionX Technology 21
Tetragenetics Enters Into Licensing Agreement With Amgen For Antibodies 22
Tetragenetics Inc – Key Competitors 23
Tetragenetics Inc – Key Employees 24
Tetragenetics Inc – Locations And Subsidiaries 25
Head Office 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Tetragenetics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tetragenetics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tetragenetics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Tetragenetics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
TetraGenetics Raises Funds through Venture Financing 11
Tetragenetics Raises USD1 Million in Venture Financing 12
Tetragenetics Raises USD0.3 Million in Financing Round 13
Tetragenetics Raises US$0.5 Million In Venture Financing 14
Tetragenetics Raises US$3 Million In Venture Financing 15
Tetragenetics Enters into Agreement with LifeArc 16
Tetragenetics Enters into Partnership with Modiquest Research 17
Tetragenetics Enters into Agreement with Theranyx 18
Tetragenetics Enters into Agreement with arGEN-X, Crystal Biosciences and Sevion Therapeutics 19
Tetragenetics Enters into Agreement with MedImmune for Drug Discovery Program 20
Tetragenetics Enters Into Option For Licensing Agreement With Pfizer For SionX Technology 21
Tetragenetics Enters Into Licensing Agreement With Amgen For Antibodies 22
Tetragenetics Inc, Key Competitors 23
Tetragenetics Inc, Key Employees 24

List of Figures
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tetragenetics Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Tetragenetics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hitachi Zosen Corp (7004):企業の財務・戦略的SWOT分析
    Hitachi Zosen Corp (7004) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • MAN SE:企業の戦略・SWOT・財務分析
    MAN SE - Strategy, SWOT and Corporate Finance Report Summary MAN SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • IHC Engineering Business Ltd:企業の戦略・SWOT・財務情報
    IHC Engineering Business Ltd - Strategy, SWOT and Corporate Finance Report Summary IHC Engineering Business Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • StealthGas Inc (GASS):企業の財務・戦略的SWOT分析
    Summary StealthGas Inc (StealthGas) is an oil and gas shipping company that offers seaborne and oil and gas transportation services. The company provides transportation of petroleum and petrochemical gas products in liquefied forms. StealthGas transports byproducts of crude oil and natural gas inclu …
  • Universities Superannuation Scheme Ltd:企業の戦略的SWOT分析
    Universities Superannuation Scheme Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Capital Power Corporation (CPX)-エネルギー分野:企業M&A・提携分析
    Summary Capital Power Corporation (CPC) is a power producer that develops, acquires, operates, optimizes, and builds power generation facilities. It generates electricity from energy-efficient technology, lower-carbon fuel, and renewable sources using a range of energy sources. The company owns supe …
  • The Northwestern Mutual Life Insurance Company:企業の戦略・SWOT・財務情報
    The Northwestern Mutual Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary The Northwestern Mutual Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Deutsche Telekom AG:戦略・SWOT・企業財務分析
    Deutsche Telekom AG - Strategy, SWOT and Corporate Finance Report Summary Deutsche Telekom AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • PepsiCo Inc:企業のM&A・事業提携・投資動向
    PepsiCo Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PepsiCo Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Cascade Metrix LLC:企業の製品パイプライン分析
    Summary Cascade Metrix LLC (CMI) is a medical technology company that offers automated POC blood analyzer for critical care. The company offers novel micro-volume IV extension kits, and automated glucose monitoring systems, among others. It also provides a revolutionary ex vivo blood analysis system …
  • Five Prime Therapeutics Inc (FPRX):企業の財務・戦略的SWOT分析
    Five Prime Therapeutics Inc (FPRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • RPC Group Plc:企業の戦略的SWOT分析
    RPC Group Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Texas Instruments Inc (TXN):企業の財務・戦略的SWOT分析
    Texas Instruments Inc (TXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Beerenberg Corp. AS:企業の戦略的SWOT分析
    Beerenberg Corp. AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • FRONTEO, Inc. (2158):企業の財務・戦略的SWOT分析
    FRONTEO, Inc. (2158) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Investment Technology Group, Inc.
    Investment Technology Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Investment Technology Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Astron Corp Ltd (ATR):企業の財務・戦略的SWOT分析
    Astron Corp Ltd (ATR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Milliken & Company:企業の戦略・SWOT・財務情報
    Milliken & Company - Strategy, SWOT and Corporate Finance Report Summary Milliken & Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Perdue Farms Inc.:企業の戦略・SWOT・財務分析
    Perdue Farms Inc. - Strategy, SWOT and Corporate Finance Report Summary Perdue Farms Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • DowDuPont Inc (DWDP):企業の財務・戦略的SWOT分析
    DowDuPont Inc (DWDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆